ID   HLaC-79
AC   CVCL_6648
SY   HLaC 79; HLac 79; HLAC79; HLaC'79; HlaC79
DR   BTO; BTO:0004021
DR   Cosmic; 932294
DR   Wikidata; Q54889837
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3138611;
RX   PubMed=6837290;
RX   PubMed=7543833;
RX   PubMed=8679156;
RX   PubMed=15495191;
RX   PubMed=20947470;
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191).
CC   Derived from metastatic site: Cervical lymph node.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 20-05-21; Version: 17
//
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RA   Carey T.E.;
RT   "Head and neck tumor cell lines.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.79-120; Academic Press; New York (1994).
//
RX   PubMed=3138611; DOI=10.1177/019459988809800603;
RA   Wustrow T.P., Raffael A., Valet G.K.;
RT   "Multiparametric flow cytometry of human squamous cell carcinoma lines
RT   from the head and neck.";
RL   Otolaryngol. Head Neck Surg. 98:552-557(1988).
//
RX   PubMed=6837290; DOI=10.3109/00016488309130956;
RA   Zenner H.P., Herrmann I.F., Bremer W., Stahl-Mauge C.;
RT   "Head and neck carcinoma models. In vivo reproduction in athymic mice
RT   and in vitro culture.";
RL   Acta Oto-Laryngol. 95:371-381(1983).
//
RX   PubMed=7543833; DOI=10.1007/BF00121908;
RA   Tomson A.M., Scholma J., Dijkhuizen T., Wijnakker A.P.M.,
RA   van der Werf M., de Jong K.M.D., van Leeuwen M.B.M., Koning J.G.J.;
RT   "Characterization of human larynx carcinoma cell lines HLaC'79 and
RT   HLaC'82: a common origin but diverged malignancies.";
RL   Clin. Exp. Metastasis 13:319-327(1995).
//
RX   PubMed=8679156; DOI=10.1007/BF00178278;
RA   Koldovsky P., Haas I., Bier H., Ganzer U.;
RT   "Immunohistochemical examination of 11 cell lines derived from human
RT   head and neck squamous cell carcinomas, their recurrences or
RT   metastases.";
RL   Eur. Arch. Otorhinolaryngol. 252:359-365(1995).
//
RX   PubMed=15495191; DOI=10.1002/gcc.20119;
RA   Raschke S., Balz V., Efferth T., Schulz W.A., Florl A.R.;
RT   "Homozygous deletions of CDKN2A caused by alternative mechanisms in
RT   various human cancer cell lines.";
RL   Genes Chromosomes Cancer 42:58-67(2005).
//
RX   PubMed=20947470; DOI=10.1186/2047-783X-15-8-337;
RA   Schuler P.J., Trellakis S., Greve J., Bas M., Bergmann C., Bolke E.,
RA   Lehnerdt G., Mattheis S., Albers A.E., Brandau S., Lang S.,
RA   Whiteside T.L., Bier H., Hoffmann T.K.;
RT   "In vitro chemosensitivity of head and neck cancer cell lines.";
RL   Eur. J. Med. Res. 15:337-344(2010).
//